Latest News

Connecting COVID-19 Research to Impact on Patients With Atopic Dermatitis
Connecting COVID-19 Research to Impact on Patients With Atopic Dermatitis

March 18th 2024

Two recent studies delve into outcomes of pediatric populations with atopic conditions and an overview of patient outcomes utilizing a Mendelian randomization analysis.

Red, Itchy, And AD Until Proven Otherwise
Red, Itchy, And AD Until Proven Otherwise

March 12th 2024

Discussing Late-Breaking INTEGUMENT-PED Data With Arcutis' Chief Medical Officer, Patrick Burnett, MD, PhD, FAAD
Discussing Late-Breaking INTEGUMENT-PED Data With Arcutis' Chief Medical Officer, Patrick Burnett, MD, PhD, FAAD

March 10th 2024

Lawrence Eichenfield, MD: Outlining Late-Breaking INTEGUMENT-PED Data for Roflumilast in Pediatric Patients
Lawrence Eichenfield, MD: Outlining Late-Breaking INTEGUMENT-PED Data for Roflumilast in Pediatric Patients

March 10th 2024

The Impact of Atopic Dermatitis on Childhood Growth: Insights from the PEDISTAD Study
The Impact of Atopic Dermatitis on Childhood Growth: Insights from the PEDISTAD Study

March 10th 2024

Video Series
Video Interviews
Podcasts

More News

© 2024 MJH Life Sciences

All rights reserved.